Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

• Status: Completed
• Trial end date: 2018-11-30
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Collaborators: Medivation, Inc.; Pfizer

Criteria

Inclusion Criteria:

• no history of treatment with enzalutamide

Exclusion Criteria:

-